Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein

Background. Curcumin is a polyphenol that has pharmacological activity that can inhibit tumor cell growth and induce apoptosis through various mechanisms. However, the specifc mechanism of curcumin cytotoxicity remains controversial because of many anti- and pro-apoptotic signaling pathways in vario...

Full description

Bibliographic Details
Main Authors: N. A. Rahmah, H. Harliansyah, F. D. Suyatna, M. Kanoko, P. Rustamadji, J. Prihartono, A. Bustami, S. J. Haryono, B. S. Hernowo
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2023-01-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/2378
_version_ 1797875722658775040
author N. A. Rahmah
H. Harliansyah
F. D. Suyatna
M. Kanoko
P. Rustamadji
J. Prihartono
A. Bustami
S. J. Haryono
B. S. Hernowo
author_facet N. A. Rahmah
H. Harliansyah
F. D. Suyatna
M. Kanoko
P. Rustamadji
J. Prihartono
A. Bustami
S. J. Haryono
B. S. Hernowo
author_sort N. A. Rahmah
collection DOAJ
description Background. Curcumin is a polyphenol that has pharmacological activity that can inhibit tumor cell growth and induce apoptosis through various mechanisms. However, the specifc mechanism of curcumin cytotoxicity remains controversial because of many anti- and pro-apoptotic signaling pathways in various cell types.This study aims to examine the relationship among curcumin on RASSF1A, Bax protein levels, and caspase-3 activity in supporting the apoptotic mechanism in CSA03 breast cancer cells.Material and Methods. Curcumin administration to cancer cells is based on differences in dosage with 24-hour incubation. Cytotoxicity after curcumin administration was determined using MTS. RASSF1A and Bax protein levels were tested through ELISA. Caspase-3 activity was used to determine apoptosis and was tested using fow cytometry.Results. The results indicated that curcumin had a cytotoxicity effect of 40.85 µg/mL. At concentrations of 40 µg/mL and 50 µg/mL, curcumin increases levels of protein RASSF1A (∆ = 26.53% and 47.35%, respectively), Bax (∆ = 48.79% and 386.15%), and caspase-3 (∆ = 1,678.51% and 1,871.889%) signifcantly.Conclusions. Curcumin exhibits anti-proliferative activity and apoptotic (Caspase-3) effects through activation of RASSF1A and Bax.
first_indexed 2024-04-10T01:52:08Z
format Article
id doaj.art-5f3333a9b0124319a47cd23677c82a6a
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2024-04-10T01:52:08Z
publishDate 2023-01-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-5f3333a9b0124319a47cd23677c82a6a2023-03-13T09:05:56ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682023-01-01216919810.21294/1814-4861-2022-21-6-91-981066Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 proteinN. A. Rahmah0H. Harliansyah1F. D. Suyatna2M. Kanoko3P. Rustamadji4J. Prihartono5A. Bustami6S. J. Haryono7B. S. Hernowo8Университет ЯрсиУниверситет ЯрсиУниверситет ИндонезииУниверситет ИндонезииУниверситет ИндонезииУниверситет ИндонезииУниверситет ИндонезииБольница Национального онкологического центра DharmaisУниверситет ПаджаджаранBackground. Curcumin is a polyphenol that has pharmacological activity that can inhibit tumor cell growth and induce apoptosis through various mechanisms. However, the specifc mechanism of curcumin cytotoxicity remains controversial because of many anti- and pro-apoptotic signaling pathways in various cell types.This study aims to examine the relationship among curcumin on RASSF1A, Bax protein levels, and caspase-3 activity in supporting the apoptotic mechanism in CSA03 breast cancer cells.Material and Methods. Curcumin administration to cancer cells is based on differences in dosage with 24-hour incubation. Cytotoxicity after curcumin administration was determined using MTS. RASSF1A and Bax protein levels were tested through ELISA. Caspase-3 activity was used to determine apoptosis and was tested using fow cytometry.Results. The results indicated that curcumin had a cytotoxicity effect of 40.85 µg/mL. At concentrations of 40 µg/mL and 50 µg/mL, curcumin increases levels of protein RASSF1A (∆ = 26.53% and 47.35%, respectively), Bax (∆ = 48.79% and 386.15%), and caspase-3 (∆ = 1,678.51% and 1,871.889%) signifcantly.Conclusions. Curcumin exhibits anti-proliferative activity and apoptotic (Caspase-3) effects through activation of RASSF1A and Bax.https://www.siboncoj.ru/jour/article/view/2378baxcaspase-3куркуминcsa03rassf1a
spellingShingle N. A. Rahmah
H. Harliansyah
F. D. Suyatna
M. Kanoko
P. Rustamadji
J. Prihartono
A. Bustami
S. J. Haryono
B. S. Hernowo
Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein
Сибирский онкологический журнал
bax
caspase-3
куркумин
csa03
rassf1a
title Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein
title_full Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein
title_fullStr Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein
title_full_unstemmed Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein
title_short Curcumin as an anti-proliferative agent in breast cancer through RASSF1A, Bax, and caspase-3 protein
title_sort curcumin as an anti proliferative agent in breast cancer through rassf1a bax and caspase 3 protein
topic bax
caspase-3
куркумин
csa03
rassf1a
url https://www.siboncoj.ru/jour/article/view/2378
work_keys_str_mv AT narahmah curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT hharliansyah curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT fdsuyatna curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT mkanoko curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT prustamadji curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT jprihartono curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT abustami curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT sjharyono curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein
AT bshernowo curcuminasanantiproliferativeagentinbreastcancerthroughrassf1abaxandcaspase3protein